Table 5 Most frequent patterns of antibiotic treatment
Variable | All patients | CAPUCI I group | CAPUCI II group | p value |
|---|---|---|---|---|
(n = 144) | (n = 72) | (n = 72) | ||
Cephalosporin and macrolide | 58 (40.1) | 35 (48.5) | 23 (32.0) | 0.06 |
Ceftriaxone/cefotaxime and clarithromycin | 29 (20.1) | 27 (37.5) | 2 (2.8) | <0.01 |
Ceftriaxone/cefotaxime and azithromycin | 18 (12.4) | 0 (0) | 18 (25.0) | <0.01 |
Other cephalosporin and macrolide | 11 (7.6) | 8 (11.1) | 3 (4.2) | 0.21 |
Cephalosporin and quinolone | 31 (21.5) | 6 (8.4) | 25 (34.6) | <0.01 |
Cefotaxime/ceftriaxone and levofloxacin | 25 (17.3) | 4 (5.6) | 21 (29.0) | <0.01 |
Other cephalosporin and quinolone | 6 (4.2) | 2 (2.8) | 4 (5.6) | 0.68 |
Penicillin and macrolide | 9 (6.3) | 2 (2.8) | 7 (9.7) | 0.17 |
Piperacillin-tazobactam and azithromycin | 5 (3.5) | 0 (0) | 5 (6.9) | 0.06 |
Other penicillin and macrolide | 4 (2.8) | 2 (2.8) | 2 (2.8) | 1.00 |
Amoxicillin-clavulanate | 8 (5.6) | 8 (11.1) | 0 (0) | <0.01 |
Ceftriaxone/cefotaxime | 7 (4.9) | 5 (6.9) | 2 (2.8) | 0.44 |
Levofloxacin | 6 (4.2) | 4 (5.6) | 2 (2.8) | 0.68 |
Miscellaneous combined therapy | 22 (15.3) | 12 (16.7) | 10 (13.9) | 0.78 |
Miscellaneous monotherapy | 3 (2.1) | 0 (0) | 3 (4.2) | 0.25 |
Overall | 144 (100) | 72 (100) | 72 (100) |